People · Operator
Named in public records as an officer, director or promoter · active 2009–2013 · Biotechnology, Other Health Care, Hospitals and Physicians
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bioscale Inc | — | Biotechnology | Series B | $44.7M | $747.7M | 2010 |
| LinguaFlex, Inc. | — | Other Health Care | Series B | $23.8M | $79.8M | 2009 |
| Andrew Technologies LLC | — | Biotechnology | Series A | $21.8M | $26.7M | 2011 |
| Avisena, Inc | — | Hospitals and Physicians | Seed | $4.1M | $11.9M | 2011 |
William Doyle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Doyle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy Langloss | 2 | 7 |
| Somu Subramaniam | 1 | 17 |
| Brian Murray | 1 | 11 |
| Isaac Cheng | 1 | 9 |
| William F. Doyle | 1 | 8 |
| Robert Chefitz | 1 | 7 |
| Paul Billings | 1 | 5 |
| John Miclot | 1 | 5 |
| Michele Ollier | 1 | 4 |
| Edward Crawley | 1 | 4 |
| Bard Geesaman | 1 | 3 |
| BARD J. GEESAMAN | 1 | 3 |
| Isaac S. Cheng | 1 | 2 |
| Ira Sanders | 1 | 2 |
| Remy Luthringer | 1 | 2 |
| John Coelho | 1 | 2 |
| Thomas A. Albright | 1 | 2 |
| Edward F. Crawley | 1 | 2 |
| Bill Doyle | 1 | 2 |
| Miguel Maseda | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.